Skip to content

CIK 0001633932

EPIX ESSA Pharma Inc.

Insider trading from SEC Form 4. Last filing Oct 15, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Signals

Open-market buys and sells at ESSA Pharma Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
12WeakBvf Partners L P/il
owner
sell
$293
156 shares
-0%-
57ModerateBiotech Growth N V
owner
sell
$12M
7,879,583 shares
-100%-

Transactions

The last 23 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 9, 2025Marella Thorell
director
DDisposition to issuer
Common Shares
-2,881--0Oct 15, 2025
Oct 9, 2025John Alexander Martin
director
DDisposition to issuer
Common Shares
-14,299--0Oct 15, 2025
Oct 9, 2025Scott Requadt
director
DDisposition to issuer
Common Shares
-30,002--0Oct 15, 2025
Oct 9, 2025Richard M Glickman
director
DDisposition to issuer
Common Shares
-43,240--0Oct 15, 2025
Oct 9, 2025David S. Wood
Chief Financial Officer
DDisposition to issuer
Common Shares
-33,343--0Oct 15, 2025
Oct 9, 2025David Ross Parkinson
President and CEO
DDisposition to issuer
Common Shares
-65,675--0Oct 15, 2025
Oct 9, 2025Franklin M Berger
director
DDisposition to issuer
Common Shares
-784,404--0Oct 15, 2025
Oct 9, 2025Bvf Partners L P/il
owner
UTender of shares
Common Stock
-6,194,145--0Oct 14, 2025
Oct 9, 2025Bvf Partners L P/il
owner
UTender of shares
Common Stock
-4,726,743--0Oct 14, 2025
Oct 9, 2025Bvf Partners L P/il
owner
UTender of shares
Common Stock
-560,797--0Oct 14, 2025
Aug 5, 2025Bvf Partners L P/il
owner
XIn-the-money exercise
Common Stock
+1,481,634$0.00$1486,194,224Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
XIn-the-money exercise
Common Stock
+1,235,030$0.00$1244,726,809Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
XIn-the-money exercise
Common Stock
+203,336$0.00$20560,808Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
SOpen-market sale
Common Stock
-79$1.88$1486,194,145Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
SOpen-market sale
Common Stock
-66$1.88$1244,726,743Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
SOpen-market sale
Common Stock
-11$1.88$21560,797Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
XIn-the-money exercise
Pre-funded Warrantsderivative
-1,481,634$0.00$00Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
XIn-the-money exercise
Pre-funded Warrantsderivative
-1,235,030$0.00$00Aug 7, 2025
Aug 5, 2025Bvf Partners L P/il
owner
XIn-the-money exercise
Pre-funded Warrantsderivative
-203,336$0.00$00Aug 7, 2025
Nov 1, 2024Biotech Growth N V
owner
SOpen-market sale
Common Shares
-2,000,000$1.53$3.1M5,879,583Nov 5, 2024
Nov 1, 2024Biotech Growth N V
owner
SOpen-market sale
Common Shares
-2,000,000$1.53$3.1M3,879,583Nov 5, 2024
Nov 1, 2024Biotech Growth N V
owner
SOpen-market sale
Common Shares
-2,000,000$1.53$3.1M1,879,583Nov 5, 2024
Nov 1, 2024Biotech Growth N V
owner
SOpen-market sale
Common Shares
-1,879,583$1.51$2.8M0Nov 5, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.